Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists (Q73327845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

C L Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G C Rosenfeld

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T F Burks

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

409-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

The role of CCK caerulein, and CCK antagonists in nociception

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Accurate measurement of intestinal transit in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

CCK 8 analgesia and hyperalgesia after intrathecal administration in the rat: Comparison with CCK-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900341-5

7 January 2021

10.1016/S0196-9781(96)00341-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145429%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference